Because cystic fibrosis affects multiple organ systems, including the lungs and digestive system, people with the condition often need care from a team of healthcare professionals. Cystic fibrosis ...
As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...
Ivacaftor oral granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for the treatment of cystic fibrosis (CF) in patients aged four months and older who have at least one mutation in ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics ... with the recent progress in our Phase 2 studies in people with cystic fibrosis and OTC deficiency. ARCT-032 has the potential to address ...
Wockhardt Limited announced that its innovative antibiotic, Zaynich (Zidebactam/Cefepime), demonstrated over 97% clinical efficacy in treating serious infections ...
A new deal to train Ukrainian drone operators will boost the country’s ability to launch long-range, jam-resistant strikes, the president of Shield AI told Defense One. In an interview ...
Notably, the company has announced a new Phase 2b study for its lead asset, bexotegrast, in progressive pulmonary fibrosis (PPF), which is set to begin in the second half of 2025. This new study ...
The electric vehicle charging company ChargePoint has introduced new cut-resistant cables as a theft and vandalism deterrent. In addition to the new cables, ChargePoint added a new alarm system ...
AP The latest measure creates a new “ember-resistant” zone, dubbed “zone zero,” that bars things like brush, wooden fencing, furniture, sheds and mulch within 5 feet (1.5 meters ...
Aluminium price witnessed a strong rise last week. The Aluminium Futures contract traded on the Multi Commodity Exchange (MCX) has risen sharply from a low around ₹237 per kg. It touched a high ...
(RTTNews) - Immuron Limited (IMRN), an Australian-based biopharmaceutical company, Wednesday, announced a new research collaboration with Monash University to develop therapeutic drug candidates ...